I want to report a cheap medication UBS analyst Carsten Riek said even a sale of the Alabamaplant for $1.5 billion in cash would not suffice to rule out arights issue of 0.5 billion to 1 billion euros as ThyssenKrupp'sgearing ratio would still be at about 143 percent.